Imaging of Disease Dynamics during Meningococcal Sepsis
Open Access
- 21 February 2007
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 2 (2) , e241
- https://doi.org/10.1371/journal.pone.0000241
Abstract
Neisseria meningitidis is a human pathogen that causes septicemia and meningitis with high mortality. The disease progression is rapid and much remains unknown about the disease process. The understanding of disease development is crucial for development of novel therapeutic strategies and vaccines against meningococcal disease. The use of bioluminescent imaging combined with a mouse disease model allowed us to investigate the progression of meningococcal sepsis over time. Injection of bacteria in blood demonstrated waves of bacterial clearance and growth, which selected for Opa-expressing bacteria, indicating the importance of this bacterial protein. Further, N. meningitidis accumulated in the thyroid gland, while thyroid hormone T4 levels decreased. Bacteria reached the mucosal surfaces of the upper respiratory tract, which required expression of the meningococcal PilC1 adhesin. Surprisingly, PilC1 was dispensable for meningococcal growth in blood and for crossing of the blood-brain barrier, indicating that the major role of PilC1 is to interact with mucosal surfaces. This in vivo study reveals disease dynamics and organ targeting during meningococcal disease and presents a potent tool for further investigations of meningococcal pathogenesis and vaccines in vivo. This might lead to development of new strategies to improve the outcome of meningococcal disease in human patients.Keywords
This publication has 42 references indexed in Scilit:
- The Obligate Human Pathogen, Neisseria gonorrhoeae, Is PolyploidPLoS Biology, 2006
- Evaluation of Recombinant Lipidated P2086 Protein as a Vaccine Candidate for Group B Neisseria meningitidis in a Murine Nasal Challenge ModelInfection and Immunity, 2005
- The PilC adhesin of the Neisseria type IV pilus – binding specificities and new insights into the nature of the host cell receptorMolecular Microbiology, 2005
- Experimental disease models for the assessment of meningococcal vaccinesVaccine, 2005
- Four Viruses, Two Bacteria, and One Receptor: Membrane Cofactor Protein (CD46) as Pathogens' MagnetJournal of Virology, 2004
- Neisseria meningitidisUndergoes PilC Phase Variation and PilE Sequence Variation during Invasive DiseaseThe Journal of Infectious Diseases, 2004
- Thyroid Hormone Supplementation in Sepsis: An Experimental StudySurgery Today, 2003
- The infant rat model adapted to evaluate human sera for protective immunity to group B meningococciVaccine, 1999
- Recombinational reassortment among opa genes from ET-37 complex Neisseria meningitidis isolates of diverse geographical originsMicrobiology, 1998
- Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male.The Journal of Experimental Medicine, 1994